 | • レポートコード：MRC2102QY8815 • 出版社/出版日： / 2021年1月 • レポート形態：英文、PDF、130ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品、医療 |
| Single User | ￥592,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥888,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,184,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYリサーチ社の本調査レポートでは、世界の髄膜炎菌ワクチン市場について種類別（髄膜炎A+C、髄膜炎ACWY135、髄膜炎B）、用途別（医療、病院）、地域別（米国、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・髄膜炎菌ワクチン市場の概要 ・世界の主要地域別髄膜炎菌ワクチン市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界の髄膜炎菌ワクチン市場規模2015-2026：種類別（髄膜炎A+C、髄膜炎ACWY135、髄膜炎B） ・世界の髄膜炎菌ワクチン市場規模2015-2026：用途別（医療、病院） ・髄膜炎菌ワクチンの米国市場規模2015-2020 ・髄膜炎菌ワクチンのヨーロッパ市場規模2015-2020 ・髄膜炎菌ワクチンの中国市場規模2015-2020 ・髄膜炎菌ワクチンの日本市場規模2015-2020 ・髄膜炎菌ワクチンの東南アジア市場規模2015-2020 ・髄膜炎菌ワクチンのインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 ・髄膜炎菌ワクチンの製造コスト分析 ・販売チャネル、流通業者、顧客 ・髄膜炎菌ワクチンの市場動向・機会・課題 ・調査の結論 |
Market Analysis and Insights: Global Meningitis Vaccine Market
The global Meningitis Vaccine market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026.
Global Meningitis Vaccine Scope and Market Size
The global Meningitis Vaccine market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Meningitis Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2015-2026.
Segment by Type, the Meningitis Vaccine market is segmented into
Meningitis A+C
Meningitis ACWY135
Meningitis B
Segment by Application, the Meningitis Vaccine market is segmented into
Medical Care
Hospital
The Meningitis Vaccine market is analysed and market size information is provided by regions (countries). Segment by Application, the Meningitis Vaccine market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Meningitis Vaccine Market Share Analysis
Meningitis Vaccine market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Meningitis Vaccine business, the date to enter into the Meningitis Vaccine market, Meningitis Vaccine product introduction, recent developments, etc.
The major vendors covered:
GlaxoSmithKline
Baxter International
Sanofi Pasteur
Merck
Novartis
Pfizer
Hualan
Zhejiang Tianyuan
Beijing Tiantan Biological
1 Meningitis Vaccine Market Overview
1.1 Meningitis Vaccine Product Scope
1.2 Meningitis Vaccine Segment by Type
1.2.1 Global Meningitis Vaccine Sales by Type (2020-2026)
1.2.2 Meningitis A+C
1.2.3 Meningitis ACWY135
1.2.4 Meningitis B
1.3 Meningitis Vaccine Segment by Application
1.3.1 Global Meningitis Vaccine Sales Comparison by Application (2020-2026)
1.3.2 Medical Care
1.3.3 Hospital
1.4 Meningitis Vaccine Market Estimates and Forecasts (2015-2026)
1.4.1 Global Meningitis Vaccine Sales Growth Rate (2015-2026)
1.4.2 Global Meningitis Vaccine Revenue and Growth Rate (2015-2026)
1.4.3 Global Meningitis Vaccine Price Trends (2015-2026)
2 Meningitis Vaccine Estimate and Forecast by Region
2.1 Global Meningitis Vaccine Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Meningitis Vaccine Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Meningitis Vaccine Sales Market Share by Region (2015-2020)
2.2.2 Global Meningitis Vaccine Revenue Market Share by Region (2015-2020)
2.3 Global Meningitis Vaccine Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Meningitis Vaccine Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Meningitis Vaccine Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Meningitis Vaccine Estimates and Projections (2015-2026)
2.4.2 Europe Meningitis Vaccine Estimates and Projections (2015-2026)
2.4.3 China Meningitis Vaccine Estimates and Projections (2015-2026)
2.4.4 Japan Meningitis Vaccine Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Meningitis Vaccine Estimates and Projections (2015-2026)
2.4.6 India Meningitis Vaccine Estimates and Projections (2015-2026)
3 Global Meningitis Vaccine Competition Landscape by Players
3.1 Global Top Meningitis Vaccine Players by Sales (2015-2020)
3.2 Global Top Meningitis Vaccine Players by Revenue (2015-2020)
3.3 Global Meningitis Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Meningitis Vaccine as of 2019)
3.4 Global Meningitis Vaccine Average Price by Company (2015-2020)
3.5 Manufacturers Meningitis Vaccine Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Meningitis Vaccine Players (Opinion Leaders)
4 Global Meningitis Vaccine Market Size by Type
4.1 Global Meningitis Vaccine Historic Market Review by Type (2015-2020)
4.1.1 Global Meningitis Vaccine Sales Market Share by Type (2015-2020)
4.1.2 Global Meningitis Vaccine Revenue Market Share by Type (2015-2020)
4.1.3 Global Meningitis Vaccine Price by Type (2015-2020)
4.2 Global Meningitis Vaccine Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Meningitis Vaccine Sales Forecast by Type (2021-2026)
4.2.2 Global Meningitis Vaccine Revenue Forecast by Type (2021-2026)
4.2.3 Global Meningitis Vaccine Price Forecast by Type (2021-2026)
5 Global Meningitis Vaccine Market Size by Application
5.1 Global Meningitis Vaccine Historic Market Review by Application (2015-2020)
5.1.1 Global Meningitis Vaccine Sales Market Share by Application (2015-2020)
5.1.2 Global Meningitis Vaccine Revenue Market Share by Application (2015-2020)
5.1.3 Global Meningitis Vaccine Price by Application (2015-2020)
5.2 Global Meningitis Vaccine Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Meningitis Vaccine Sales Forecast by Application (2021-2026)
5.2.2 Global Meningitis Vaccine Revenue Forecast by Application (2021-2026)
5.2.3 Global Meningitis Vaccine Price Forecast by Application (2021-2026)
6 United States Meningitis Vaccine Market Facts & Figures
6.1 United States Meningitis Vaccine Sales Market Share by Company (2015-2020)
6.2 United States Meningitis Vaccine Sales Market Share by Type (2015-2020)
6.3 United States Meningitis Vaccine Sales Market Share by Application (2015-2020)
7 Europe Meningitis Vaccine Market Facts & Figures
7.1 Europe Meningitis Vaccine Sales Market Share by Company (2015-2020)
7.2 Europe Meningitis Vaccine Sales Market Share by Type (2015-2020)
7.3 Europe Meningitis Vaccine Sales Market Share by Application (2015-2020)
8 China Meningitis Vaccine Market Facts & Figures
8.1 China Meningitis Vaccine Sales Market Share by Company (2015-2020)
8.2 China Meningitis Vaccine Sales Market Share by Type (2015-2020)
8.3 China Meningitis Vaccine Sales Market Share by Application (2015-2020)
9 Japan Meningitis Vaccine Market Facts & Figures
9.1 Japan Meningitis Vaccine Sales Market Share by Company (3015-3030)
9.2 Japan Meningitis Vaccine Sales Market Share by Type (2015-2020)
9.3 Japan Meningitis Vaccine Sales Market Share by Application (2015-2020)
10 Southeast Asia Meningitis Vaccine Market Facts & Figures
10.1 Southeast Asia Meningitis Vaccine Sales Market Share by Company (2015-2020)
10.2 Southeast Asia Meningitis Vaccine Sales Market Share by Type (2015-2020)
10.3 Southeast Asia Meningitis Vaccine Sales Market Share by Application (2015-2020)
11 India Meningitis Vaccine Market Facts & Figures
11.1 India Meningitis Vaccine Sales Market Share by Company (2015-2020)
11.2 India Meningitis Vaccine Sales Market Share by Type (2015-2020)
11.3 India Meningitis Vaccine Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Meningitis Vaccine Business
12.1 GlaxoSmithKline
12.1.1 GlaxoSmithKline Corporation Information
12.1.2 GlaxoSmithKline Business Overview
12.1.3 GlaxoSmithKline Meningitis Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.1.4 GlaxoSmithKline Meningitis Vaccine Products Offered
12.1.5 GlaxoSmithKline Recent Development
12.2 Baxter International
12.2.1 Baxter International Corporation Information
12.2.2 Baxter International Business Overview
12.2.3 Baxter International Meningitis Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Baxter International Meningitis Vaccine Products Offered
12.2.5 Baxter International Recent Development
12.3 Sanofi Pasteur
12.3.1 Sanofi Pasteur Corporation Information
12.3.2 Sanofi Pasteur Business Overview
12.3.3 Sanofi Pasteur Meningitis Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Sanofi Pasteur Meningitis Vaccine Products Offered
12.3.5 Sanofi Pasteur Recent Development
12.4 Merck
12.4.1 Merck Corporation Information
12.4.2 Merck Business Overview
12.4.3 Merck Meningitis Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Merck Meningitis Vaccine Products Offered
12.4.5 Merck Recent Development
12.5 Novartis
12.5.1 Novartis Corporation Information
12.5.2 Novartis Business Overview
12.5.3 Novartis Meningitis Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Novartis Meningitis Vaccine Products Offered
12.5.5 Novartis Recent Development
12.6 Pfizer
12.6.1 Pfizer Corporation Information
12.6.2 Pfizer Business Overview
12.6.3 Pfizer Meningitis Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Pfizer Meningitis Vaccine Products Offered
12.6.5 Pfizer Recent Development
12.7 Hualan
12.7.1 Hualan Corporation Information
12.7.2 Hualan Business Overview
12.7.3 Hualan Meningitis Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Hualan Meningitis Vaccine Products Offered
12.7.5 Hualan Recent Development
12.8 Zhejiang Tianyuan
12.8.1 Zhejiang Tianyuan Corporation Information
12.8.2 Zhejiang Tianyuan Business Overview
12.8.3 Zhejiang Tianyuan Meningitis Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Zhejiang Tianyuan Meningitis Vaccine Products Offered
12.8.5 Zhejiang Tianyuan Recent Development
12.9 Beijing Tiantan Biological
12.9.1 Beijing Tiantan Biological Corporation Information
12.9.2 Beijing Tiantan Biological Business Overview
12.9.3 Beijing Tiantan Biological Meningitis Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Beijing Tiantan Biological Meningitis Vaccine Products Offered
12.9.5 Beijing Tiantan Biological Recent Development
13 Meningitis Vaccine Manufacturing Cost Analysis
13.1 Meningitis Vaccine Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Meningitis Vaccine
13.4 Meningitis Vaccine Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Meningitis Vaccine Distributors List
14.3 Meningitis Vaccine Customers
15 Market Dynamics
15.1 Meningitis Vaccine Market Trends
15.2 Meningitis Vaccine Opportunities and Drivers
15.3 Meningitis Vaccine Market Challenges
15.4 Meningitis Vaccine Market Restraints
15.5 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Meningitis Vaccine Sales (K MT) Growth Rate by Type (2020-2026) (US$ Million)
Table 2. Global Meningitis Vaccine Sales (K MT) Comparison by Application (2020-2026) (US$ Million)
Table 3. Global Market Meningitis Vaccine Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Meningitis Vaccine Sales (K MT) by Region (2015-2020)
Table 5. Global Meningitis Vaccine Sales Market Share by Region (2015-2020)
Table 6. Global Meningitis Vaccine Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Meningitis Vaccine Revenue Share by Region (2015-2020)
Table 8. Global Meningitis Vaccine Sales (K MT) Forecast by Region (2021-2026)
Table 9. Global Meningitis Vaccine Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Meningitis Vaccine Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Meningitis Vaccine Revenue Share Forecast by Region (2021-2026)
Table 12. Global Meningitis Vaccine (K MT) of Key Companies (2015-2020)
Table 13. Global Meningitis Vaccine Sales Share by Company (2015-2020)
Table 14. Global Meningitis Vaccine Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Meningitis Vaccine Revenue Share by Company (2015-2020)
Table 16. Global Meningitis Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Meningitis Vaccine as of 2019)
Table 17. Global Meningitis Vaccine Average Price (USD/MT) of Key Company (2015-2020)
Table 18. Manufacturers Meningitis Vaccine Manufacturing Sites and Area Served
Table 19. Manufacturers Meningitis Vaccine Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Meningitis Vaccine Players
Table 22. Global Meningitis Vaccine Sales (K MT) by Type (2015-2020)
Table 23. Global Meningitis Vaccine Sales Share by Type (2015-2020)
Table 24. Global Meningitis Vaccine Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Meningitis Vaccine Price (K MT) by Type (2015-2020)
Table 26. Global Meningitis Vaccine Sales Share by Type (2021-2026)
Table 27. Global Meningitis Vaccine Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Meningitis Vaccine Revenue Share by Type (2021-2026)
Table 29. Global Meningitis Vaccine Price (K MT) by Type (2021-2026)
Table 30. Global Meningitis Vaccine Sales (K MT) by Application (2015-2020)
Table 31. Global Meningitis Vaccine Sales Share by Application (2015-2020)
Table 32. Global Meningitis Vaccine Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Meningitis Vaccine Price (K MT) by Application (2015-2020)
Table 34. Global Meningitis Vaccine Sales (K MT) by Application (2021-2026)
Table 35. Global Meningitis Vaccine Sales Share by Application (2021-2026)
Table 36. Global Meningitis Vaccine Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Meningitis Vaccine Revenue Share by Application (2021-2026)
Table 38. Global Meningitis Vaccine Price (K MT) by Application (2021-2026)
Table 39. United States Meningitis Vaccine Sales (K MT) by Company (2015-2020)
Table 40. United States Meningitis Vaccine Sales Market Share by Company (2015-2020)
Table 41. United States Meningitis Vaccine Sales (K MT) by Type (2015-2020)
Table 42. United States Meningitis Vaccine Sales Market Share by Type (2015-2020)
Table 43. United States Meningitis Vaccine Sales (K MT) by Application (2015-2020)
Table 44. United States Meningitis Vaccine Sales Market Share by Application (2015-2020)
Table 45. Europe Meningitis Vaccine Sales (K MT) by Company (2015-2020)
Table 46. Europe Meningitis Vaccine Sales Market Share by Company (2015-2020)
Table 47. Europe Meningitis Vaccine Sales (K MT) by Type (2015-2020)
Table 48. Europe Meningitis Vaccine Sales Market Share by Type (2015-2020)
Table 49. Europe Meningitis Vaccine Sales (K MT) by Application (2015-2020)
Table 50. Europe Meningitis Vaccine Sales Market Share by Type (2015-2020)
Table 51. China Meningitis Vaccine Sales (K MT) by Company (2015-2020)
Table 52. China Meningitis Vaccine Sales Market Share by Company (2015-2020)
Table 53. China Meningitis Vaccine Sales (K MT) by Type (2015-2020)
Table 54. China Meningitis Vaccine Sales Market Share by Type (2015-2020)
Table 55. China Meningitis Vaccine Sales (K MT) by Application (2015-2020)
Table 56. China Meningitis Vaccine Sales Market Share by Application (2015-2020)
Table 57. Japan Meningitis Vaccine Sales (K MT) by Company (2015-2020)
Table 58. Japan Meningitis Vaccine Sales Market Share by Company (2015-2020)
Table 59. Japan Meningitis Vaccine Sales (K MT) by Type (2015-2020)
Table 60. Japan Meningitis Vaccine Sales Market Share by Type (2015-2020)
Table 61. Japan Meningitis Vaccine Sales (K MT) by Application (2015-2020)
Table 62. Japan Meningitis Vaccine Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Meningitis Vaccine Sales (K MT) by Company (2015-2020)
Table 64. Southeast Asia Meningitis Vaccine Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Meningitis Vaccine Sales (K MT) by Type (2015-2020)
Table 66. Southeast Asia Meningitis Vaccine Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Meningitis Vaccine Sales (K MT) by Type (2015-2020)
Table 68. Southeast Asia Meningitis Vaccine Sales Market Share by Application (2015-2020)
Table 69. India Meningitis Vaccine Sales (K MT) by Company (2015-2020)
Table 70. India Meningitis Vaccine Sales Market Share by Company (2015-2020)
Table 71. India Meningitis Vaccine Sales (K MT) by Type (2015-2020)
Table 72. India Meningitis Vaccine Sales Market Share by Type (2015-2020)
Table 73. India Meningitis Vaccine Sales (K MT) by Application (2015-2020)
Table 74. India Meningitis Vaccine Sales Market Share by Application (2015-2020)
Table 75. GlaxoSmithKline Corporation Information
Table 76. GlaxoSmithKline Description and Business Overview
Table 77. GlaxoSmithKline Meningitis Vaccine Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 78. GlaxoSmithKline Meningitis Vaccine Product
Table 79. GlaxoSmithKline Recent Development
Table 80. Baxter International Corporation Information
Table 81. Baxter International Description and Business Overview
Table 82. Baxter International Meningitis Vaccine Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 83. Baxter International Meningitis Vaccine Product
Table 84. Baxter International Recent Development
Table 85. Sanofi Pasteur Corporation Information
Table 86. Sanofi Pasteur Description and Business Overview
Table 87. Sanofi Pasteur Meningitis Vaccine Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 88. Sanofi Pasteur Meningitis Vaccine Product
Table 89. Sanofi Pasteur Recent Development
Table 90. Merck Corporation Information
Table 91. Merck Description and Business Overview
Table 92. Merck Meningitis Vaccine Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 93. Merck Meningitis Vaccine Product
Table 94. Merck Recent Development
Table 95. Novartis Corporation Information
Table 96. Novartis Description and Business Overview
Table 97. Novartis Meningitis Vaccine Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 98. Novartis Meningitis Vaccine Product
Table 99. Novartis Recent Development
Table 100. Pfizer Corporation Information
Table 101. Pfizer Description and Business Overview
Table 102. Pfizer Meningitis Vaccine Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 103. Pfizer Meningitis Vaccine Product
Table 104. Pfizer Recent Development
Table 105. Hualan Corporation Information
Table 106. Hualan Description and Business Overview
Table 107. Hualan Meningitis Vaccine Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 108. Hualan Meningitis Vaccine Product
Table 109. Hualan Recent Development
Table 110. Zhejiang Tianyuan Corporation Information
Table 111. Zhejiang Tianyuan Meningitis Vaccine Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 112. Zhejiang Tianyuan Description and Business Overview
Table 113. Zhejiang Tianyuan Meningitis Vaccine Product
Table 114. Zhejiang Tianyuan Recent Development
Table 115. Beijing Tiantan Biological Corporation Information
Table 116. Beijing Tiantan Biological Meningitis Vaccine Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 117. Beijing Tiantan Biological Description and Business Overview
Table 118. Beijing Tiantan Biological Meningitis Vaccine Product
Table 119. Beijing Tiantan Biological Recent Development
Table 120. Production Base and Market Concentration Rate of Raw Material
Table 121. Key Suppliers of Raw Materials
Table 122. Meningitis Vaccine Distributors List
Table 123. Meningitis Vaccine Customers List
Table 124. Meningitis Vaccine Market Key Trends
Table 125. Meningitis Vaccine Key Opportunities and Drivers
Table 126. Meningitis Vaccine Market Challenges
Table 127. Research Programs/Design for This Report
Table 128. Key Data Information from Secondary Sources
Table 129. Key Data Information from Primary Sources
List of Figures
Figure 1. Meningitis Vaccine Product Picture
Figure 2. Global Meningitis Vaccine Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Meningitis Vaccine Market Share by Application in 2020 & 2026
Figure 6. Medical Care Examples
Figure 7. Hospital Examples
Figure 8. Global Meningitis Vaccine Sales (K MT) Growth Rate (2015-2026)
Figure 9. Global Meningitis Vaccine Revenue (US$ Million) Growth Rate (2015-2026)
Figure 10. Global Meningitis Vaccine Price Trends Growth Rate (2015-2026) (USD/MT)
Figure 11. Global Meningitis Vaccine Revenue Market Share by Region: 2015 VS 2020
Figure 12. Global Meningitis Vaccine Revenue Market Share by Region: 2021 VS 2026
Figure 13. United States Meningitis Vaccine Revenue (Million USD) Growth Rate (2015-2026)
Figure 14. United States Meningitis Vaccine Sales (K MT) Growth Rate (2015-2026)
Figure 15. Europe Meningitis Vaccine Revenue (Million USD) Growth Rate (2015-2026)
Figure 16. Europe Meningitis Vaccine Sales (Million USD) Growth Rate (2015-2026)
Figure 17. China Meningitis Vaccine Revenue (Million USD) Growth Rate (2015-2026)
Figure 18. China Meningitis Vaccine Sales (Million USD) and Growth Rate (2015-2026)
Figure 19. Japan Meningitis Vaccine Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. Japan Meningitis Vaccine Sales (Million USD) Growth Rate (2015-2026)
Figure 21. Southeast Asia Meningitis Vaccine Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Meningitis Vaccine Sales (Million USD) Growth Rate (2015-2026)
Figure 23. India Meningitis Vaccine Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. India Meningitis Vaccine Sales (Million USD) Growth Rate (2015-2026)
Figure 25. Global 5 Largest Meningitis Vaccine Players Market Share by Revenue in Meningitis Vaccine 2015 & 2019
Figure 26. Meningitis Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 27. Global Meningitis Vaccine Revenue Share by Type (2015-2020)
Figure 28. Global Meningitis Vaccine Revenue Growth Rate by Type in 2015 & 2019
Figure 29. Global Meningitis Vaccine Revenue Share by Application (2015-2020)
Figure 30. Global Meningitis Vaccine Revenue Growth Rate by Application in 2015 & 2019
Figure 31. United States Meningitis Vaccine Sales Market Share by Type in 2019
Figure 32. United States Meningitis Vaccine Sales Market Share by Type in 2019
Figure 33. Europe Meningitis Vaccine Sales Market Share by Company in 2019
Figure 34. Europe Meningitis Vaccine Sales Market Share by Type in 2019
Figure 35. Europe Meningitis Vaccine Sales Market Share by Application in 2019
Figure 36. China Meningitis Vaccine Sales Market Share by Company in 2019
Figure 37. China Meningitis Vaccine Sales Market Share by Type in 2019
Figure 38. China Meningitis Vaccine Sales Market Share by Application in 2019
Figure 39. Japan Meningitis Vaccine Sales Market Share by Company in 2019
Figure 40. Japan Meningitis Vaccine Sales Market Share by Type in 2019
Figure 41. Japan Meningitis Vaccine Sales Market Share by Application in 2019
Figure 42. Southeast Asia Meningitis Vaccine Sales Market Share by Company in 2019
Figure 43. Southeast Asia Meningitis Vaccine Sales Market Share by Type in 2019
Figure 44. Southeast Asia Meningitis Vaccine Sales Market Share by Application in 2019
Figure 45. India Meningitis Vaccine Sales Market Share by Company in 2019
Figure 46. India Meningitis Vaccine Sales Market Share by Type in 2019
Figure 47. India Meningitis Vaccine Sales Market Share by Application in 2019
Figure 48. Key Raw Materials Price Trend
Figure 49. Manufacturing Cost Structure of Meningitis Vaccine
Figure 50. Manufacturing Process Analysis of Meningitis Vaccine
Figure 51. Meningitis Vaccine Industrial Chain Analysis
Figure 52. Channels of Distribution
Figure 53. Distributors Profiles
Figure 54. Porter's Five Forces Analysis
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed
麻疹（はしか）ワクチンの世界市場レポート2020 Measles vaccine is made by inoculation of attenuated strain of measles virus into chicken embryo cells, culture and harvesting of virus venom, and then freeze-drying. Injection into the lateral deltoid muscle attachment of the upper arm can prevent measles. Market Analysis and Insights: Global Measl…- 点鼻ワクチンの世界市場レポート2020 Nasal Spray Vaccine refers to a vaccine injected through the nose, which is mostly used for influenza. The FluMist is the only alternative to the flu shot without a needle and is given in the form of a nasal spray. Nasal Spray Vaccine is widely sales for Child and Adult The most proportion of Nasal …
- 23価肺炎球菌多糖体ワクチンの世界市場レポート2020 23-Valent Pneumococcal Polysaccharide Vaccine is a kind of vaccine used to prevent infection caused by pneumococcal bacteria. 23-Valent Pneumococcal Polysaccharide Vaccine contains 23 of the most common types of pneumococcal bacteria. 23-Valent Pneumococcal Polysaccharide Vaccine is for use only in …
- インフルエンザワクチンの世界市場レポート2020 Influenza vaccines, also known as flu shots, are vaccines that protect against influenza. A new version of the vaccine is developed twice a year as the influenza virus rapidly changes. Most provide modest to high protection against influenza; however, each year this varies. Evidence in adults over 6…
- ヒト用予防ワクチンの世界市場レポート2020 Vaccination in the body of a healthy person causes the person to produce antibodies and obtain specific immunity in the absence of disease. For example, BCG vaccination, smallpox vaccination and so on. Market Analysis and Insights: Global Prophylactic Human Vaccine Market The global Prophylactic Hum…